In this Book

summary
Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one’s expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. 

Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. .
 

Table of Contents

  1. Title Page, Copyright
  2. pp. i-iv
  3. restricted access Download |
  1. Contents
  2. pp. v-viii
  3. restricted access Download |
  1. Contributors
  2. pp. ix-xvi
  3. restricted access Download |
  1. The Concept of Iatrogenicity
  2. John B. Kostis and Ihor B. Gussak
  3. pp. 1-2
  4. restricted access Download |
  1. Part I: Medical Harm
  1. 1. Iatrogenicity: Definition, History, and Modern Context
  2. Maria L. Gussak, Ihor B. Gussak, and John B. Kostis
  3. pp. 5-15
  4. restricted access Download |
  1. 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions
  2. Miriam A. Gonzalez-Siegel and Stephen K. Jones
  3. pp. 16-21
  4. restricted access Download |
  1. 3. Risk Management: The Medical Center Administration Perspective
  2. Stephen K. Jones and Miriam A. Gonzalez-Siegel
  3. pp. 22-27
  4. restricted access Download |
  1. 4. Iatrogenicity from the Patient’s Perspective
  2. Jeanne M. Dobrzynski
  3. pp. 28-33
  4. restricted access Download |
  1. 5. A Naturopathic Perspective on Iatrogenesis
  2. Christie Fleetwood
  3. pp. 34-44
  4. restricted access Download |
  1. Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
  1. 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes
  2. Ihor B. Gussak, Gan-Xin Yan, Arshad Jahangir, Georg Gussak, and John B. Kostis
  3. pp. 47-61
  4. restricted access Download |
  1. 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death
  2. Aalap Narichania, Yasuhiro Yokoyama, and Win K. Shen
  3. pp. 62-76
  4. restricted access Download |
  1. 8. Chemotherapy-Induced Cardiomyopathy
  2. Edo Y. Birati and Mariell Jessup
  3. pp. 77-87
  4. restricted access Download |
  1. 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension
  2. Thomas D. Giles, Gary E. Sander, and Camilo Fernandez
  3. pp. 88-100
  4. restricted access Download |
  1. 10. Antihypertensive Drug–Induced Iatrogenic Cardiovascular Syndromes
  2. Rigas G. Kalaitzidis and George L. Bakris
  3. pp. 101-115
  4. restricted access Download |
  1. 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
  2. Evelyn R. Hermes-DeSantis and Joseph A. Barone
  3. pp. 116-142
  4. restricted access Download |
  1. 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia
  2. Costas Thomopoulos and Thomas Makris
  3. pp. 143-155
  4. restricted access Download |
  1. 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect
  2. Gloria Bachmann, Nancy Phillips, and Margaret Rees
  3. pp. 156-162
  4. restricted access Download |
  1. 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents
  2. Konstantinos Tsioufis, Dimitris Konstantinidis, Nikolaos Vogiatzakis, Kyriakos Dimitriadis, and Dimitris Tousoulis
  3. pp. 163-174
  4. restricted access Download |
  1. 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System
  2. Konstantinos Stavropoulos, Chrysoula Boutari, Konstantinos Imprialos, Vasilios Papademetriou, and Michael Doumas
  3. pp. 175-187
  4. restricted access Download |
  1. 16. Iatrogenicity and Antianginal Drugs
  2. Abel E. Moreyra and William J. Kostis
  3. pp. 188-193
  4. restricted access Download |
  1. 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?
  2. Rajesh Kumar
  3. pp. 194-204
  4. restricted access Download |
  1. 18. Cardiovascular Iatrogenicity in Older Adults
  2. Ariba Khan, Fatima Ali, Vibha Iyengar, Yuya Hagiwara, VJ Periyakoil, Neela Patel, and Michael Malone
  3. pp. 205-218
  4. restricted access Download |
  1. Part III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
  1. 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology
  2. Christina Dösch, Dirk Loßnitzer, and Theano Papavassiliu
  3. pp. 221-232
  4. restricted access Download |
  1. 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology
  2. Naga Venkata Pothineni, Aatish Garg, Hakan Paydak, and Jawahar L. Mehta
  3. pp. 233-242
  4. restricted access Download |
  1. 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries
  2. Michael Behnes, Tobias Becher, Stefan Baumann, Uzair Ansari, and Ibrahim Akin
  3. pp. 243-254
  4. restricted access Download |
  1. 22. Iatrogenic Aspects of Cardiac Electrophysiology
  2. Boris Rudic, Erol Tülümen, Volker Liebe, and Martin Borggrefe
  3. pp. 255-270
  4. restricted access Download |
  1. 23. Iatrogenic Aspects in Cardiac Device Therapy
  2. Susanne Röger and Jürgen Kuschyk
  3. pp. 271-286
  4. restricted access Download |
  1. 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic Modalities
  2. Michael S. Nolledo, Pauline O. Lerma, and Teodoro V. Santiago
  3. pp. 287-306
  4. restricted access Download |
  1. Part IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications
  1. 25. Trained Athletes
  2. Gino Seravalle, Guido Grassi, and Giuseppe Mancia
  3. pp. 309-317
  4. restricted access Download |
  1. 26. Sports Cardiology
  2. Giovanni Campanile
  3. pp. 318-326
  4. restricted access Download |
  1. 27. Dangers of Lifestyle Modification Advice
  2. Giovanni Campanile
  3. pp. 327-334
  4. restricted access Download |
  1. Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine
  1. 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications
  2. Sulaiman Sultan, Ahad Jahangir, Ihor B. Gussak, A. Jamil Tajik, and Arshad Jahangir
  3. pp. 337-369
  4. restricted access Download |
  1. 29. Interactions Between Supplements and Medications
  2. Sulaiman Sultan, Ahad Jahangir, Ihor B. Gussak, John B. Kostis, A. Jamil Tajik, and Arshad Jahangir
  3. pp. 370-414
  4. restricted access Download |
  1. Index
  2. pp. 415-432
  3. restricted access Download |

Additional Information

ISBN
9780813586434
Related ISBN
9780813586410
MARC Record
OCLC
1029759751
Pages
448
Launched on MUSE
2018-04-13
Language
English
Open Access
No
Back To Top

This website uses cookies to ensure you get the best experience on our website. Without cookies your experience may not be seamless.